{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:40:33Z","timestamp":1790804433140,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2023YFC2706300"],"award-info":[{"award-number":["2023YFC2706300"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s12325-025-03204-9","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:38:15Z","timestamp":1748479095000},"page":"3562-3575","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Real-Life Growth Hormone Treatment Patterns in Children from China: A Report from Two Databases"],"prefix":"10.1007","volume":"42","author":[{"given":"Wei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3748-4817","authenticated-orcid":false,"given":"Xiaoping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"issue":"Suppl 3","key":"3204_CR1","first-page":"841","volume":"5","author":"P Bang","year":"2008","unstructured":"Bang P. Statement 3: a low serum IGF-I Level in idiopathic short stature patients indicates partial GH insensitivity. Pediatr Endocrinol Rev PER. 2008;5(Suppl 3):841\u20136.","journal-title":"Pediatr Endocrinol Rev PER"},{"key":"3204_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000502231","volume":"92","author":"PF Collett-Solberg","year":"2019","unstructured":"Collett-Solberg PF, Ambler G, Backeljauw PF, Bidlingmaier M, Biller BMK, Boguszewski MCS, et al. Diagnosis, genetics, and therapy of short stature in children: a growth hormone research society international perspective. Horm Res Paediatr. 2019;92:1\u201314.","journal-title":"Horm Res Paediatr"},{"key":"3204_CR3","unstructured":"WHO child growth standards: length\/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. https:\/\/www.who.int\/publications\/i\/item\/924154693X."},{"key":"3204_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ghir.2015.07.004","volume":"25","author":"C H\u00f8ybye","year":"2015","unstructured":"H\u00f8ybye C, Cohen P, Hoffman AR, Ross R, Biller BMK, Christiansen JS. Status of long-acting-growth hormone preparations\u20142015. Growth Horm IGF Res. 2015;25:201\u20136.","journal-title":"Growth Horm IGF Res"},{"key":"3204_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1530\/eje.1.02191","volume":"155","author":"K Stochholm","year":"2006","unstructured":"Stochholm K, Gravholt CH, Laursen T, J\u00f8rgensen JO, Laurberg P, Andersen M, et al. Incidence of GH deficiency\u2014a nationwide study. Eur J Endocrinol. 2006;155:61\u201371.","journal-title":"Eur J Endocrinol"},{"key":"3204_CR6","doi-asserted-by":"publisher","unstructured":"Huang S, Chen Z, Chen R, Zhang Z, Sun J, Chen H (2022) Analysis of risk factors and construction of a prediction model for short stature in children. Front Pediatr. https:\/\/doi.org\/10.3389\/fped.2022.1006011\/full","DOI":"10.3389\/fped.2022.1006011\/full"},{"key":"3204_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/ped4.12233","volume":"5","author":"F Li","year":"2021","unstructured":"Li F, Liu K, Zhao Q, Chen J, Liu L, Xie Q, et al. Prevalence of short stature among children in China: a systematic review. Pediatr Investig. 2021;5:140\u20137.","journal-title":"Pediatr Investig"},{"key":"3204_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026634","volume":"9","author":"J Ma","year":"2019","unstructured":"Ma J, Pei T, Dong F, Dong Y, Yang Z, Chen J, et al. Spatial and demographic disparities in short stature among school children aged 7\u201318 years: a nation-wide survey in China, 2014. BMJ Open. 2019;9: e026634.","journal-title":"BMJ Open"},{"key":"3204_CR9","unstructured":"Causes of short stature\u2014UpToDate. https:\/\/www.uptodate.com\/contents\/causes-of-short-stature"},{"key":"3204_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nrendo.2018.22","volume":"14","author":"MB Ranke","year":"2018","unstructured":"Ranke MB, Wit JM. Growth hormone\u2014past, present and future. Nat Rev Endocrinol. 2018;14:285\u2013300.","journal-title":"Nat Rev Endocrinol"},{"key":"3204_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.864908","author":"J Yuan","year":"2022","unstructured":"Yuan J, Fu J, Wei H. A randomized controlled phase 3 study on the efficacy and safety of recombinant human growth hormone in children with idiopathic short stature. Front Endocrinol. 2022. https:\/\/doi.org\/10.3389\/fendo.2022.864908.","journal-title":"Front Endocrinol"},{"key":"3204_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1530\/EJE-16-0905","volume":"177","author":"X Luo","year":"2017","unstructured":"Luo X, Hou L, Liang L, Dong G, Shen S, Zhao Z, et al. Long-acting PEGylated recombinant human growth hormone (Jintrolong) for children with growth hormone deficiency: phase II and phase III multicenter, randomized studies. Eur J Endocrinol. 2017;177:195\u2013205.","journal-title":"Eur J Endocrinol"},{"key":"3204_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12902-022-01101-8","volume":"22","author":"J Chen","year":"2022","unstructured":"Chen J, Zhong Y, Wei H, Chen S, Su Z, Liu L, et al. Polyethylene glycol recombinant human growth hormone in Chinese prepubertal slow-growing short children: doses reported in a multicenter real-world study. BMC Endocr Disord. 2022;22:201.","journal-title":"BMC Endocr Disord"},{"key":"3204_CR14","unstructured":"NCT06110910. Long-term efficacy and safety evaluation of growth hormone in children in China (CGLS) | ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT06110910."},{"key":"3204_CR15","doi-asserted-by":"publisher","unstructured":"Li H, Ji CY, Zong XN, Zhang YQ. [Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years]. Zhonghua Er Ke Za Zhi. 2009;47(7):487\u201392. https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1310.2009.07.003","DOI":"10.3760\/cma.j.issn.0578-1310.2009.07.003"},{"key":"3204_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.637209\/full","author":"KCJ Yuen","year":"2021","unstructured":"Yuen KCJ, Miller BS, Boguszewski CL, Hoffman AR. Usefulness and potential pitfalls of long-acting growth hormone analogs. Front Endocrinol. 2021. https:\/\/doi.org\/10.3389\/fendo.2021.637209\/full.","journal-title":"Front Endocrinol"},{"key":"3204_CR17","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1515\/jpem-2021-0735","volume":"35","author":"H Du","year":"2022","unstructured":"Du H, Wu D, Yi P, Bai X, Luo Y, Yang H, et al. Evaluation of efficacy and safety of long-acting PEGylated recombinant human growth hormone (Jintrolong) for patients with growth hormone deficiency. J Pediatr Endocrinol Metab. 2022;35:511\u20137.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"3204_CR18","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1210\/clinem\/dgad039","volume":"108","author":"L Hou","year":"2023","unstructured":"Hou L, Huang K, Gong C, Luo F, Wei H, Liang L, et al. Long-term pegylated GH for children with GH deficiency: a large, prospective, real-world study. J Clin Endocrinol Metab. 2023;108:2078\u201386.","journal-title":"J Clin Endocrinol Metab"},{"key":"3204_CR19","doi-asserted-by":"publisher","first-page":"955809","DOI":"10.3389\/fphar.2022.955809","volume":"13","author":"Z Jiang","year":"2022","unstructured":"Jiang Z, Chen X, Dong G, Lou Y, Zhang J, Cheng X, et al. Short-term efficacy and safety of a lower dose of polyethylene glycol recombinant human growth hormone in children with growth hormone deficiency: a randomized, dose-comparison study. Front Pharmacol. 2022;13:955809.","journal-title":"Front Pharmacol"},{"key":"3204_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.6065\/apem.2346206.103","volume":"29","author":"ME Geffner","year":"2024","unstructured":"Geffner ME, Ranke MB, Wajnrajch MP, for the Pfizer International Growth Database Strategic Executive Committee, Strategic Advisory Board, and International Board. An overview of growth hormone therapy in pediatric cases documented in the Kabi International Growth Study (Pfizer International Growth Database). Ann Pediatr Endocrinol Metab. 2024;29:3\u201311.","journal-title":"Ann Pediatr Endocrinol Metab."},{"key":"3204_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ghir.2007.11.004","volume":"18","author":"JM Wit","year":"2008","unstructured":"Wit JM, Clayton PE, Rogol AD, Savage MO, Saenger PH, Cohen P. Idiopathic short stature: definition, epidemiology, and diagnostic evaluation. Growth Horm IGF Res. 2008;18:89\u2013110.","journal-title":"Growth Horm IGF Res"},{"key":"3204_CR22","doi-asserted-by":"publisher","first-page":"S178","DOI":"10.4103\/2230-8210.104034","volume":"16","author":"MO Savage","year":"2012","unstructured":"Savage MO, Bang P. The variability of responses to growth hormone therapy in children with short stature. Indian J Endocrinol Metab. 2012;16:S178\u201384.","journal-title":"Indian J Endocrinol Metab"},{"key":"3204_CR23","first-page":"1575","volume":"81","author":"G Johannsson","year":"1996","unstructured":"Johannsson G, Bjarnason R, Bramnert M, Carlsson LM, Degerblad M, Manhem P, et al. The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender. J Clin Endocrinol Metab. 1996;81:1575\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"3204_CR24","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1507\/endocrj.43.Suppl_S19","volume":"43","author":"K Fujieda","year":"1996","unstructured":"Fujieda K, Hanew K, Hirano T, Igarashi Y, Nishi Y, Tachibana K, et al. Growth response to growth hormone therapy in patients with different degrees of growth hormone deficiency. Endocr J. 1996;43:S19-25.","journal-title":"Endocr J"},{"key":"3204_CR25","first-page":"426","volume":"51","author":"Subspecialty Group of Endocrinologic, Hereditary and Metabolic Diseases, Society of Pediatrics, Chinese Medical Association The Editorial Board, Chinese Journal of Pediatrics","year":"2013","unstructured":"Subspecialty Group of Endocrinologic, Hereditary and Metabolic Diseases, Society of Pediatrics, Chinese Medical Association The Editorial Board, Chinese Journal of Pediatrics. Recommendations for the clinical use of recombinant human growth hormone in children. Zhonghua Er Ke Za Zhi Chin J Pediatr. 2013;51:426\u201332.","journal-title":"Zhonghua Er Ke Za Zhi Chin J Pediatr."},{"issue":"45","key":"3204_CR26","first-page":"180","volume":"2007","author":"Subspecialty Group of Endocinologic, Hereditary and Metabolic Diseases, Society of Pediatrics, Chinese Medical Association","year":"2007","unstructured":"Subspecialty Group of Endocinologic, Hereditary and Metabolic Diseases, Society of Pediatrics, Chinese Medical Association. Brief report of work of the Subspecialty Group of Endocrinologic, Hereditary and Metabolic Diseases, The Society of Pediatrics, Chinese Medical Association. Zhonghua Er Ke Za Zhi Chin J Pediatr. 2007;2007(45):180.","journal-title":"Zhonghua Er Ke Za Zhi Chin J Pediatr."},{"key":"3204_CR27","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1210\/endrev\/bnad002","volume":"44","author":"ACS Hokken-Koelega","year":"2023","unstructured":"Hokken-Koelega ACS, Van Der Steen M, Boguszewski MCS, Cianfarani S, Dahlgren J, Horikawa R, et al. International consensus guideline on small for gestational age: etiology and management from infancy to early adulthood. Endocr Rev. 2023;44:539\u201365.","journal-title":"Endocr Rev"},{"key":"3204_CR28","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.1210\/jc.2004-2513","volume":"90","author":"SF Kemp","year":"2005","unstructured":"Kemp SF, Kuntze J, Attie KM, Maneatis T, Butler S, Frane J, et al. Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature. J Clin Endocrinol Metab. 2005;90:5247\u201353.","journal-title":"J Clin Endocrinol Metab"},{"key":"3204_CR29","doi-asserted-by":"publisher","first-page":"206","DOI":"10.23736\/S0026-4946.20.05821-1","volume":"72","author":"JG Halas","year":"2020","unstructured":"Halas JG, Grimberg A. Dilemmas of growth hormone treatment for GH deficiency and idiopathic short stature: defining, distinguishing, and deciding. Minerva Pediatr. 2020;72:206\u201325.","journal-title":"Minerva Pediatr"},{"key":"3204_CR30","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1530\/EJE-16-1024","volume":"177","author":"M Polak","year":"2017","unstructured":"Polak M, Blair J, Kotnik P, Pournara E, Pedersen BT, Rohrer TR. Early growth hormone treatment start in childhood growth hormone deficiency improves near adult height: analysis from NordiNet\u00ae International Outcome Study. Eur J Endocrinol. 2017;177:421\u20139.","journal-title":"Eur J Endocrinol"},{"key":"3204_CR31","doi-asserted-by":"publisher","DOI":"10.1159\/000539068","author":"CJ Partsch","year":"2024","unstructured":"Partsch CJ, Land C, Pf\u00e4ffle RW, Schwab KO, Sommer H. Potential for optimization of growth hormone treatment in children with growth hormone deficiency, small for gestational age, and Turner syndrome in Germany: data from the PATRO\u00ae children study. Horm Res Paediatr. 2024. https:\/\/doi.org\/10.1159\/000539068.","journal-title":"Horm Res Paediatr"},{"key":"3204_CR32","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1210\/jc.2009-1563","volume":"95","author":"IP Hughes","year":"2010","unstructured":"Hughes IP, Choong CS, Cotterill A, Harris M, Davies PSW. Gender bias in children receiving growth hormone treatment. J Clin Endocrinol Metab. 2010;95:1191\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"3204_CR33","first-page":"401","volume":"105","author":"XL Bao","year":"1992","unstructured":"Bao XL, Shi YF, Du YC, Liu R, Deng JY, Gao SM. Prevalence of growth hormone deficiency of children in Beijing. Chin Med J (Engl). 1992;105:401\u20135.","journal-title":"Chin Med J (Engl)"},{"key":"3204_CR34","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.eprac.2023.04.004","volume":"29","author":"C Kamoun","year":"2023","unstructured":"Kamoun C, Miller VA, Feudtner C, Friedrich EA, Grimberg A. Views on short stature of female vs male endocrine pediatric patients undergoing provocative growth hormone testing and their parents. Endocr Pract. 2023;29:517\u201324.","journal-title":"Endocr Pract"},{"key":"3204_CR35","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000452150","volume":"86","author":"A Grimberg","year":"2016","unstructured":"Grimberg A, DiVall SA, Polychronakos C, Allen DB, Cohen LE, Quintos JB, et al. Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency. Horm Res Paediatr. 2016;86:361\u201397.","journal-title":"Horm Res Paediatr"},{"key":"3204_CR36","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1210\/clinem\/dgac517","volume":"107","author":"M Maghnie","year":"2022","unstructured":"Maghnie M, Ranke MB, Geffner ME, Vlachopapadopoulou E, Ib\u00e1\u00f1ez L, Carlsson M, et al. Safety and efficacy of pediatric growth hormone therapy: results from the full KIGS cohort. J Clin Endocrinol Metab. 2022;107:3287\u2013301.","journal-title":"J Clin Endocrinol Metab"},{"issue":"97","key":"3204_CR37","first-page":"1","volume":"2024","author":"ESPE","year":"2024","unstructured":"ESPE. Abstracts. Horm Res Paediatr. 2024;2024(97):1\u2013736.","journal-title":"Horm Res Paediatr"},{"key":"3204_CR38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000351025","volume":"79","author":"JM Wit","year":"2013","unstructured":"Wit JM, Ranke MB, Albertsson-Wikland K, Carrascosa A, Rosenfeld RG, Van Buuren S, et al. Personalized approach to growth hormone treatment: clinical use of growth prediction models. Horm Res Paediatr. 2013;79:257\u201370.","journal-title":"Horm Res Paediatr"},{"key":"3204_CR39","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2005.18.10.949\/html","author":"F Darendeliler","year":"2005","unstructured":"Darendeliler F, Berbero\u01e7lu M, \u00d6cal G, Ad\u0131yaman P, Bundak R, G\u00fcn\u00f6z H, et al. Response to growth hormone with respect to pubertal status on increased dose in idiopathic growth hormone deficiency: an analysis of Turkish children in the KIGS database (Pfizer international growth study). J Pediatr Endocrinol Metab. 2005. https:\/\/doi.org\/10.1515\/JPEM.2005.18.10.949\/html.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"3204_CR40","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1080\/03007995.2016.1190701","volume":"32","author":"N Tanaka","year":"2016","unstructured":"Tanaka N, Kurose T, Seino Y. Therapeutic inertia or individualization? Delay in clinical management of type 2 diabetes mellitus. Curr Med Res Opin. 2016;32:1477\u20138.","journal-title":"Curr Med Res Opin"},{"key":"3204_CR41","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3810\/pgm.2010.01.2105","volume":"122","author":"SD Nesbitt","year":"2010","unstructured":"Nesbitt SD. Overcoming therapeutic inertia in patients with hypertension. Postgrad Med. 2010;122:118\u201324.","journal-title":"Postgrad Med"},{"key":"3204_CR42","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1186\/s12872-024-04109-1","volume":"24","author":"YL Niriayo","year":"2024","unstructured":"Niriayo YL, Girmay S, Tesfay N, Gidey K, Asgedom SW. Therapeutic inertia and contributing factors among ambulatory patients with hypertension. BMC Cardiovasc Disord. 2024;24:523.","journal-title":"BMC Cardiovasc Disord"},{"issue":"81","key":"3204_CR43","first-page":"1087","volume":"2024","author":"N Wang","year":"1979","unstructured":"Wang N, Von Huben A, Marschner S, Nelson MR, Nolde JM, Schlaich MP, et al. Therapeutic inertia with initial low-dose quadruple combination therapy for hypertension: results from the QUARTET trial. Hypertens Dallas Tex. 1979;2024(81):1087\u201394.","journal-title":"Hypertens Dallas Tex"},{"key":"3204_CR44","first-page":"801","volume":"38","author":"The Subspecialty Group of Endocrinology H and MD the Society of Pediatrics, Chinese Medical Association, Adolescent Health and Medical Professional Committee CMDA, Development FRC of P, Metabolism CS of PE","year":"2023","unstructured":"The Subspecialty Group of Endocrinology H and MD the Society of Pediatrics, Chinese Medical Association, Adolescent Health and Medical Professional Committee CMDA, Development FRC of P, Metabolism CS of PE. Chinese expert consensus on the diagnosis and treatment of children with idiopathic short stature. Chin J Pract Pediatr. 2023;38:801\u201313.","journal-title":"Chin J Pract Pediatr."},{"key":"3204_CR45","doi-asserted-by":"publisher","first-page":"e2121","DOI":"10.1210\/clinem\/dgz149","volume":"105","author":"BS Miller","year":"2020","unstructured":"Miller BS, Velazquez E, Yuen KCJ. Long-acting growth hormone preparations\u2014current status and future considerations. J Clin Endocrinol Metab. 2020;105:e2121\u201333.","journal-title":"J Clin Endocrinol Metab"},{"key":"3204_CR46","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.clinthera.2008.02.017","volume":"30","author":"F Haverkamp","year":"2008","unstructured":"Haverkamp F, Johansson L, Dumas H. Observations of nonadherence to recombinant human growth hormone therapy in clinical practice. Clin Ther. 2008;30:307\u201316.","journal-title":"Clin Ther"},{"key":"3204_CR47","doi-asserted-by":"publisher","first-page":"e16223","DOI":"10.1371\/journal.pone.0016223","volume":"6","author":"WS Cutfield","year":"2011","unstructured":"Cutfield WS, Derraik JGB, Gunn AJ, Reid K, Delany T, Robinson E, et al. Non-compliance with growth hormone treatment in children is common and impairs linear growth. PLoS ONE. 2011;6:e16223 (Castro M, editor).","journal-title":"PLoS ONE"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03204-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03204-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03204-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:14:36Z","timestamp":1750479276000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03204-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["3204"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03204-9","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"24 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Wei Wu, Nan Li, Tingting Wang, and Xiaoping Luo declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Both the databases were approved by the Ethics Committee of Tongji Hospital,Tongji Medical College, Huazhong University of Science and Technology (Approval No. 2016S237 and TJ-IRB202303156, respectively), and were conducted in accordance with the principles outlined in the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}